Velocity Clinical Research - Valparaiso — Valparaiso, Indiana

Velocity Clinical Research - Valparaiso is a clinical research site located in Valparaiso, Indiana, United States 46383.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Velocity Clinical Research - Valparaiso has participated in 10 clinical trials with 4 currently active.

Therapeutic areas: Chronic Obstructive Pulmonary Disease, Asthma, SARS-CoV-2.

Sponsors: Verona Pharma plc, Bond Avillion 2 Development LP, ModernaTX, Inc..

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Velocity Clinical Research - Valparaiso?

Velocity Clinical Research - Valparaiso has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Velocity Clinical Research - Valparaiso conducted?

Velocity Clinical Research - Valparaiso has 10 clinical trials on record, with 4 currently active. Their work covers Chronic Obstructive Pulmonary Disease, Asthma, SARS-CoV-2.

Is Velocity Clinical Research - Valparaiso accredited by Crixeo Health?

Yes — Velocity Clinical Research - Valparaiso holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Velocity Clinical Research - Valparaiso?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.